Perbedaan Pakuwon Jati Tbk. dan Organon Pharma Indonesia Tbk.: Pakuwon Jati Tbk. diperdagangkan di Rp272 (kapitalisasi pasar 13,1 T, volume 24 jam 30,52 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pakuwon Jati Tbk. jauh lebih besar — sekitar 125,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PWON | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 13,1 T | 104,4 M |
Volume | 30,52 jt | — |
Lot | 305,22 rb | — |
Perputaran | 8,23 M | — |
Harga Rata-rata | 269,61 | — |
Nilai Transaksi | 8,23 M | — |
Harga Ekuilibrium Indikatif | 272 | — |
Volume Ekuilibrium Indikatif | 11,74 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Pakuwon Jati Tbk (the Company) was established based on Notarial Deed No. 281 dated September 1982 of Kartini Muljadi, S.H., notary in Jakarta. PT Pakuwon Jati, commenced operations in 1986 with the opening of Tunjungan Plaza, the first 8-floor modern shopping center in Surabaya.
Selengkapnya di halaman PWON →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →